title: The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesions.
abstract: BACKGROUND
  Even though sirolimus-eluting stents (SES) have been shown to significantly improve binary restenosis and target lesion revascularisation rates (TLR) compared to bare metal stents in diabetic patients, the revascularisation rate is still higher than those of non-diabetics. Whether a double dose (DD) of sirolimus on a stent would provide a greater reduction in neointimal hyperplasia compared to single dose (SD) SES in de novo coronary lesion of diabetic patients is unknown.
  
  
  RESULTS
  A total of 56 patients (58 lesions) were prospectively randomised in a double blind fashion in a 1:1 ratio to SD (30 lesions) versus DD (28 lesions). Procedure success was achieved in all patients. QCA results at 6 months were comparable between groups, including the primary endpoint of in-stent late lumen loss (0.19+/-0.29 mm in SD versus 0.18+/-0.33 mm in DD, p=0.96). Furthermore, restenosis was not found inside the stent in either group. By IVUS, there was no late/acquired incomplete stent apposition at follow-up, and% neointimal volume was 2.2+/-1.8% in SD versus 1.7+/-2.0% in DD, p=0.44. At 1-year clinical follow-up, there was no significant difference between groups for major events, including TLR which occurred in 1 patient in SD versus 3 patients in DD, p=0.61. Overall, there was only 1 subacute stent thrombosis (DD arm), and no late thromboses.
  
  
  CONCLUSIONS
  Double dose SES did not improve the prevention of neointimal proliferation in diabetic patients with de novo coronary lesion compare to single dose SES.
authors.affiliation: The Cardiovascular Research Foundation & Columbia University Medical Center, New York, NY, USA.
authors.forename: Ricardo A
authors.initials: RA
authors.lastname: Costa
authors.forename: J Eduardo
authors.initials: JE
authors.lastname: Sousa
authors.forename: Alexandre
authors.initials: A
authors.lastname: Abizaid
authors.forename: Aurea
authors.initials: A
authors.lastname: Chaves
authors.forename: Fausto
authors.initials: F
authors.lastname: Feres
authors.forename: Amanda G M R
authors.initials: AG
authors.lastname: Sousa
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Musumeci
authors.forename: Roxana
authors.initials: R
authors.lastname: Mehran
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Fitzgerald
authors.forename: Alexandra J
authors.initials: AJ
authors.lastname: Lansky
authors.forename: Martin B
authors.initials: MB
authors.lastname: Leon
authors.forename: Avinoam
authors.initials: A
authors.lastname: Shiran
authors.forename: David A
authors.initials: DA
authors.lastname: Halon
authors.forename: Basil S
authors.initials: BS
authors.lastname: Lewis
authors.forename: Giulio
authors.initials: G
authors.lastname: Guagliumi